AAAAAA

   
Results: 1-20 |
Results: 20

Authors: Ozsahin, H Wacker, P Brundler, MA Starobinski, M Helg, C Pastore, Y Miralbell, R Hanquinet, S Gervaix, A Chapuis, B Humbert, J
Citation: H. Ozsahin et al., Fatal myocardial aspergillosis in an immunosuppressed child, J PED H ONC, 23(7), 2001, pp. 456-459

Authors: Bieri, S Helg, C Chapuis, B Miralbell, R
Citation: S. Bieri et al., Total body irradiation before allogeneic bone marrow transplantation: Is more dose better?, INT J RAD O, 49(4), 2001, pp. 1071-1077

Authors: Cella, L Lomax, A Miralbell, R
Citation: L. Cella et al., Potential role of intensity modulated proton beams in prostate cancer radiotherapy, INT J RAD O, 49(1), 2001, pp. 217-223

Authors: Weber, DC Rouzaud, M Miralbell, R
Citation: Dc. Weber et al., Bladder opacification does not significantly influence dose distribution in conformal radiotherapy of prostate cancer, RADIOTH ONC, 59(1), 2001, pp. 95-97

Authors: Zouhair, A Ozsahin, M Schneider, D Bauer, J Jichlinski, P Roth, A Douglas, P Miralbell, R
Citation: A. Zouhair et al., Invasive bladder carcinoma: A pilot study of conservative treatment with accelerated radiotherapy and concomitant cisplatin, INT J CANC, 96(6), 2001, pp. 350-355

Authors: Miralbell, R Doriot, PA Nouet, P Rouzaud, M
Citation: R. Miralbell et al., X-ray dose to the skin in patients undergoing percutaneous transluminal coronary angioplasty, CATHET C IN, 50(3), 2000, pp. 300-306

Authors: Hugli, A Moro, D Mermillod, B Bolla, M Alberto, P Bonnefoi, H Miralbell, R
Citation: A. Hugli et al., Phase II trial of up-front accelerated thoracic radiotherapy combined withchemotherapy and optional up-front prophylactic cranial irradiation in limited small-cell lung cancer, J CL ONCOL, 18(8), 2000, pp. 1662-1667

Authors: Lomax, A Grossmann, M Cozzi, L Tercier, PA Boehringer, T Schneider, U Logean, M Volken, W Ratib, O Miralbell, R
Citation: A. Lomax et al., The exchange of radiotherapy data as part of an electronic patient-referral system, INT J RAD O, 47(5), 2000, pp. 1449-1456

Authors: Miralbell, R Cella, L Weber, D Lomax, A
Citation: R. Miralbell et al., Optimizing radiotherapy of orbital and paraorbital tumors: Intensity-modulated X-ray reams vs. intensity-modulated proton beams, INT J RAD O, 47(4), 2000, pp. 1111-1119

Authors: Weber, DC Nouet, P Rouzaud, M Miralbell, R
Citation: Dc. Weber et al., Patient positioning in prostate radiotherapy: Is prone better than supine?, INT J RAD O, 47(2), 2000, pp. 365-371

Authors: Miralbell, R von der Weid, N Bieri, S Wacker, P Berchtold, W Pastoors, B Wagner, HP
Citation: R. Miralbell et al., Pediatric medulloblastoma: Results of the Swiss Pediatric Oncology Group, INT J PED H, 6(4), 1999, pp. 275-281

Authors: Miralbell, R Maillet, P Crompton, NEA Doriot, PA Nouet, P Verin, V Harms, M Rouzaud, M
Citation: R. Miralbell et al., Skin radionecrosis after percutaneous transluminal coronary angioplasty: Dosimetric and biological assessment, J VAS INT R, 10(9), 1999, pp. 1190-1194

Authors: Miralbell, R Bieri, S Huguenin, P Feldges, A Morin, AM Garcia, E Wagner, HP Wacker, P von der Weid, N
Citation: R. Miralbell et al., Prognostic value of cerebrospinal fluid cytology in pediatric medulloblastoma, ANN ONCOL, 10(2), 1999, pp. 239-241

Authors: Weber, DC Bieri, S Kurtz, JM Miralbell, R
Citation: Dc. Weber et al., Prospective pilot study of sildenafil for treatment of postradiotherapy erectile dysfunction in patients with prostate cancer, J CL ONCOL, 17(11), 1999, pp. 3444-3449

Authors: Miralbell, R Mornex, F Greiner, R Bolla, M Storme, G Hulshof, M Bernier, J Denekamp, J Rojas, AM Pierart, M van Glabbeke, M Mirimanoff, RO
Citation: R. Miralbell et al., Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: Report of European organization for research and treatment of cancertrial 22933, J CL ONCOL, 17(10), 1999, pp. 3143-3149

Authors: Crompton, NEA Miralbell, R Rutz, HP Ersoy, F Sanal, O Wellmann, D Bieri, S Coucke, PA Emery, GC Shi, YQ Blattmann, H Ozsahin, P
Citation: Nea. Crompton et al., Altered apoptotic profiles in irradiated patients with increased toxicity, INT J RAD O, 45(3), 1999, pp. 707-714

Authors: Miralbell, R Allal, AS Mermillod, B Pastoors, B
Citation: R. Miralbell et al., The influence of field size and other radiotherapy parameters on acute toxicity in pharyngolaryngeal cancers, STRAH ONKOL, 175(2), 1999, pp. 74-77

Authors: Bieri, S Rouzaud, M Miralbell, R
Citation: S. Bieri et al., Seminoma of the testis: is scrotal shielding necessary when radiotherapy is limited to the para-aortic nodes?, RADIOTH ONC, 50(3), 1999, pp. 349-353

Authors: Miralbell, R Tolnay, M Bieri, S Probst, A Sappino, AP Berchtold, W Pepper, MS Pizzolato, G
Citation: R. Miralbell et al., Pediatric medulloblastoma: prognostic value of p53, bcl-2, Mib-1, and microvessel density, J NEURO-ONC, 45(2), 1999, pp. 103-110

Authors: de Pree, C Aapro, MS Mermillod, B Miralbell, R Graber, P Achille, E Alberto, P
Citation: C. De Pree et al., Combined chemoradiotherapy for invasive bladder cancer: A feasibility approach in a non selected population, ANTICANC R, 18(5B), 1998, pp. 3807-3812
Risultati: 1-20 |